CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

NGL FINE-CHEM LTD.

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE2544.551.95 (+0.08 %)
PREV CLOSE () 2542.60
OPEN PRICE () 2513.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4344
TODAY'S LOW / HIGH ()2475.20 2645.00
52 WK LOW / HIGH ()1293.65 2688
NSE2540.05-19.15 (-0.75 %)
PREV CLOSE() 2559.20
OPEN PRICE () 2598.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 51540
TODAY'S LOW / HIGH() 2465.00 2646.00
52 WK LOW / HIGH ()1312.2 2699.75
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1981

Management Info :

- Chairman Rahul J Nachane - Managing Director

Registered Office :

Address : 301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057

Phone : 022 26636450

Registrar's Details : Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE, NSE
NEWS
19Mar Appointment of Director
Inter alia, approved:- 1) Appointment of Mr. Dhananjay Mungale (DIN: 00..
19Mar Notice of Postal Ballot
Inter alia, approved:- 1) Appointment of Mr. Dhananjay Mungale (DIN: 00..
19Mar NGL Fine-Chem submits postal ballot no
With reference to its earlier announcement dated March 18, 2024, wherein..
11Mar NGL Fine-Chem informs about board meet
NGL Fine-Chem has informed that the fifth Board Meeting for the financia..
11Mar Appointment of Director
Inter alia to consider and approve: (1) Appointment of Mr. Dhananjay Mu..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit88.96201.19
Gross Profit 127.96 266
Operating Profit 151.38356.96
Net Sales 848.122750.52
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1455.20 (10.00%)
M.Cap ( in Cr)
846.88
Solara Active Pharma (BSE)
 551.45 (16.32%)
M.Cap ( in Cr)
1985.01
Abbott India (BSE)
 26131.85 (0.29%)
M.Cap ( in Cr)
55528.36
Windlas Biotech (BSE)
 555.05 (6.97%)
M.Cap ( in Cr)
1154.42
Concord Biotech (BSE)
 1595.25 (1.05%)
M.Cap ( in Cr)
16688.90
Shareholding Pattern
PROMOTERS 72.74%
NON-INSTITUTION 27.16%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
Motilal Oswal S&P B...0.03

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX73088.33599.34 (0.83%)
NIFTY22147.00151.15 (0.69%)
Dow Jones 37775.3822.07 (0.06%)
Nasdaq 15601.50-81.87 (-0.52%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI